CNS Pharmaceuticals Inc — Cash Flow (NASDAQ:CNSP) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 7.32 M-13.54 M-10.56 M-14.14 M-17.11 M -16.23 M Cash from investing activities 17.95 K-5 748-4 422-3 901-4 188 — Cash from financing activities 14.13 M4.51 M15.61 M4.64 M23.03 M 19.13 M Free cash flow 7.3 M-13.54 M-10.56 M-14.14 M-17.12 M -16.23 M

新闻

CNS Pharmaceuticals appoints three new executives to leadership team

CNS Pharmaceuticals’ new CEO outlines strategic overhaul

Corero Network Security公布DDoS防护平台增强功能

Corero Network Security reports DDoS protection platform enhancements

CNS制药公司股价下跌，CEO辞职

CNS Pharmaceuticals stock falls after CEO steps down

CNS制药任命Rami Levin为CEO，John Climaco辞职

CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco

CNS制药公司股东在年度会议上批准增加股份并选举董事会成员

CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting

CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript

Corero Network Security报告第三季度订单增长